- Home
- BMRN vs CIB Comparison
BMRN vs CIB Comparison
Compare BMRN & CIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- CIB
- Stock Information
- Founded
- BMRN 1996
- CIB 1945
- Country
- BMRN United States
- CIB Colombia
- Employees
- BMRN N/A
- CIB N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- CIB Commercial Banks
- Sector
- BMRN Health Care
- CIB Finance
- Exchange
- BMRN Nasdaq
- CIB Nasdaq
- Market Cap
- BMRN 9.9B
- CIB 10.6B
- IPO Year
- BMRN 1999
- CIB 1995
- Fundamental
- Price
- BMRN $54.98
- CIB $63.40
- Analyst Decision
- BMRN Buy
- CIB Sell
- Analyst Count
- BMRN 19
- CIB 4
- Target Price
- BMRN $90.26
- CIB $42.00
- AVG Volume (30 Days)
- BMRN 2.8M
- CIB 333.6K
- Earning Date
- BMRN 10-27-2025
- CIB 11-06-2025
- Dividend Yield
- BMRN N/A
- CIB 7.62%
- EPS Growth
- BMRN 59.53
- CIB 22.14
- EPS
- BMRN 2.68
- CIB 1.96
- Revenue
- BMRN $3,094,001,000.00
- CIB $6,302,057,391.00
- Revenue This Year
- BMRN $13.32
- CIB $30.39
- Revenue Next Year
- BMRN $7.51
- CIB $5.80
- P/E Ratio
- BMRN $20.49
- CIB $8.54
- Revenue Growth
- BMRN 12.39
- CIB 15.48
- 52 Week Low
- BMRN $50.76
- CIB $30.68
- 52 Week High
- BMRN $73.51
- CIB $65.00
- Technical
- Relative Strength Index (RSI)
- BMRN 57.06
- CIB 78.38
- Support Level
- BMRN $50.76
- CIB $56.60
- Resistance Level
- BMRN $53.49
- CIB $65.00
- Average True Range (ATR)
- BMRN 1.87
- CIB 1.38
- MACD
- BMRN 0.27
- CIB 0.55
- Stochastic Oscillator
- BMRN 68.79
- CIB 81.88
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About CIB BanColombia S.A.
Grupo Cibest SA formerly BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala. The Bank has the following segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking and All other segments. The majority of revenue is generated from the Banking Colombia segment.